Atlas Trials

Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast Cancer

Clinical trial NCT06106477 · RECRUITING

Trial details

NCT number
NCT06106477
Sponsor
Medical College of Wisconsin
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast Cancer
Start date
2024-07-19
Primary completion
2027-07-15
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.